BenzingaSeptember 29, 2026 at 4:35 AM NY28 Days Ago
RBC Capital Reiterates Sector Perform on Regeneron Pharmaceuticals, Maintains $737 Price Target
RBC Capital analyst Brian Abrahams reiterates Regeneron Pharmaceuticals (NASDAQ:REGN) with a Sector Perform and maintains $737 price target.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
